Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?

키워드

참고문헌 (30)

1. Huang DQ, "Changing global epidemiology of liver cancer from 2010 to 2019 : NASH is the fastest growing cause of liver cancer", Cell Metab, 34, pp.969~977 (2022)
2. Huang DQ, "Global epidemiology of NAFLD-related HCC : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 18, pp.223~238 (2021)
3. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
4. Ioannou GN, "Epidemiology and risk-stratification of NAFLDassociated HCC", J Hepatol, 75, pp.1476~1484 (2021)
5. Ng CH, "Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease : A systematic review and meta-analysis", Clin Gastroenterol Hepatol (2022)[DOI]
6. Sanyal AJ, "Prospective study of outcomes in adults with nonalcoholic fatty liver disease", N Engl J Med, 385, pp.1559~1569 (2021)
7. Singal AG, "HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis : A meta-analysis", J Hepatol, 77, pp.128~139 (2022)
8. Koh JH, "Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria : a meta-analysis of 18, 421 patients", Hepatobiliary Surg Nutr, 11, pp.78~93 (2022)
9. Reveron-Thornton RF, "Global and regional long-term survival following resection for HCC in the recent decade : A meta-analysis of 110studies", Hepatol Commun, 6, pp.1813~1826 (2022)
10. Tan DJH, "Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma : a systematic review and meta-analysis", Lancet Oncol, 23, pp.521~530 (2022)
11. Karim Seif El Dahan, "Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.207~219 (2023), 대한간학회
12. Loomba R, "AGA Clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease : Expert review", Gastroenterology, 158, pp.1822~1830 (2020)
13. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines : Management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
14. Christiane Stern, "Identification of high-risk subjects in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.196~206 (2023), 대한간학회
15. Boursier J, "Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events", J Hepatol, 76, pp.1013~1020 (2022)
16. Cholankeril G, "Current challenges and future direction in surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease", Semin Liver Dis, 43, pp.89~99 (2023)
17. Jung Hwan Yu, "Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future", Clinical and Molecular Hepatology, 29, pp.136~149 (2023), 대한간학회
18. Kim GA, "Association between non-alcoholic fatty liver disease and cancer incidence rate", J Hepatol, 68, pp.140~146 (2018)
19. Younes R, "Long-term outcomes and predictive ability of noninvasive scoring systems in patients with non-alcoholic fatty liver disease", J Hepatol, 75, pp.786~794 (2021)
20. Loosen SH, "An elevated FIB-4 score predicts liver cancer development : A longitudinal analysis from 29, 999 patients with NAFLD", J Hepatol, 76, pp.247~248 (2022)
21. Truong E, "Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients", Hepatoma Res, 8, pp.40~ (2022)
22. Bianco C, "Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores", J Hepatol, 74, pp.775~782 (2021)
23. Ioannou GN, "Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLDrelated cirrhosis for risk stratification", J Hepatol, 71, pp.523~533 (2019)
24. Lee JS, "Liver stiffness-based risk prediction model for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease", Cancers(Basel), 13, pp.4567~ (2021)
25. Tzartzeva K, "Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis : A metaanalysis", Gastroenterology, 154, pp.1706~1718 (2018)
26. Simmons O, "Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis", Aliment Pharmacol Ther, 45, pp.169~177 (2017)
27. Schoenberger H, "Dynamic changes in ultrasound quality for hepatocellular carcinoma screening in patients with cirrhosis", Clin Gastroenterol Hepatol, 20, pp.1561~1569 (2022)
28. Younes R, "Should we undertake surveillance for HCC in patients with NAFLD?", J Hepatol, 68, pp.326~334 (2018)
29. Marrero JA, "Diagnosis, staging, and management of hepatocellular carcinoma : 2018 Practice Guidance by the American Association for the Study of Liver Diseases", Hepatology, 68, pp.723~750 (2018)
30. von Felden J, "Liquid biopsy in the clinical management of hepatocellular carcinoma", Gut, 69, pp.2025~2034 (2020)

관련 논문AI추천